This piece is a companion to Optimizing Healing: A Phase-by-Phase Guide to Surgical Recovery, the flagship in this series. That article covers the general phases of healing after major trauma. This article discusses the use of enzymes in healing from trauma.
Enzyme groups (definitions)
| Proteolytic enzymes | Fibrinolytic enzymes |
|---|---|
| Bromelain, trypsin, chymotrypsin | Nattokinase, serrapeptase, lumbrokinase |
| Break down excess fibrin and protein debris locally and reduce edema. | Activate plasminogen and dissolve fibrin more aggressively. |
Serrapeptase is proteolytic by function but grouped here under fibrinolytic enzymes because of its bleeding risk profile.
Anti-Inflammatory and Anti-Edema Enzymes
After major injury, fluid and protein debris accumulate as edema. This lengthens the distance oxygen and nutrients must travel to reach repairing cells and physically obstructs fibroblasts. Fibrin exudate and hematoma compound the problem by impairing local circulation.
Proteolytic enzymes address this directly. They break down excess fibrin and protein complexes in the wound bed; the body then clears the resulting fragments through normal lymphatic drainage. Bromelain in particular reduces bradykinin and inhibits prostaglandin formation, two chemical signals that drive pain and swelling. It also supports the fibrinolysis needed for edema reabsorption. This combination accelerates the return of normal blood perfusion and oxygen levels in injured tissue. 1
Clinical evidence extends beyond surgical patients. Trials in blunt musculoskeletal trauma and long-bone fracture patients showed reduced edema, tenderness, and pain with bromelain. 2 Later orthopedic studies using the same enzyme combinations reported parallel reductions in pain, swelling, and CRP. 3
Clearing fibrin and fluid from the injury site changes the physical environment in which tissue must repair itself, and this mechanism drives faster healing.
Fibrinolytic Risk in Trauma
Fibrinolytic enzymes actively dissolve fibrin and interfere with normal clotting. This action is the basis of a proposed cardiovascular benefit, but it becomes a liability in the context of a fresh injury. Case reports have documented one patient who died from internal bleeding after taking nattokinase alone, with no other blood thinners involved. 4 Another developed prosthetic valve thrombosis after substituting nattokinase for a prescribed anticoagulant. 5
Elective surgery controls for these risks. A surgical team knows the patient’s coagulation status ahead of time, schedules a washout period for any fibrinolytic supplements, and manages bleeding within a controlled field. Trauma offers none of these safeguards. A person recovering from a major injury may already be bleeding internally, may have an undiagnosed coagulopathy from blood loss, or may be on an anticoagulant medication that has not been disclosed or accounted for. Use of fibrinolytic enzymes compounds a risk that is already present and often unmeasured.
Lumbrokinase carries the same fibrinolytic risk as nattokinase and serrapeptase, 6 though its high fibrin specificity is associated with a lower rate of systemic bleeding. 7
Edge Cases
Central Nervous System Injury
Brain and spinal cord injuries share a mechanical constraint that changes the entire calculation around fibrinolytic enzymes. Both sit inside a closed space. Any increase in bleeding or swelling inside that fixed volume raises intracranial or intraspinal pressure, which itself produces secondary injury to neural tissue.
Fibrinolytic enzymes work against recovery in this setting. They actively dissolve fibrin, and a strong fibrinolytic response in a closed space increases bleeding at exactly the moment the body needs a stable clot to control it. A study on spinal cord injury found that inhibiting the fibrinolytic system reduced bleeding and vascular permeability and improved locomotor function in the early phase of recovery. 8 That result runs directly counter to what a fibrinolytic enzyme supplement would do.
Fibrinolytic enzymes have no established role in recovery from brain or spinal cord injury and should never be self-administered in that setting.
Burns
Burn wounds create dead tissue, called eschar, that has to be removed before healing can proceed. Surgical debridement is the traditional method, but it carries its own risks, including blood loss and the accidental removal of healthy tissue alongside the damaged tissue. 9
Bromelain-based enzymatic debridement is a useful clinical tool. NexoBrid, a bromelain derivative, is used in specialized burn centers to selectively break down necrotic tissue while sparing viable tissue underneath. This is a four-hour topical treatment, and it produces roughly half the blood loss of surgical debridement while reducing how much skin grafting is needed afterward. It is also far less painful.
Bottom line
Fibrinolytic enzymes are dangerous when brain or spinal cord injury is possible. When used appropriately, proteolytic enzymes can reduce pain, inflammation, and edema, and directly support healing.
Series: Optimising Healimg This article is part of a series on surgical recovery and healing:
Optimizing Healing: A Phase-by-Phase Guide to Surgical Recovery
https://dittany.com/optimizing-healing-a-guide-to-surgical-recovery/
Optimizing Healing: Nutrient Dosing Reference
https://dittany.com/optimizing-healing-nutrient-reference-guide/
Pain Control and Healing: Using Anti-inflammatory Medications
https://dittany.com/pain-control-and-healing-using-anti-inflammatory-medications/
NSAIDs and Bone Healing: A Complicated Picture
https://dittany.com/nsaids-and-bone-healing-a-complicated-picture/
Proteolytic Enzymes for Trauma Recovery
https://dittany.com/proteolytic-enzymes-trauma-recovery/
Sources and Further Reading
- “Pineapple Enzyme (Bromelain).” Restorative Medicine. https://restorativemedicine.org/library/monographs/bromelain
- “Bromelain (Pineapple Extract).” MDedge. https://www.mdedge.com/edermatologynews/article/7813/wounds/bromelain-pineapple-extract
- “Systemic enzyme therapy for postoperative inflammation and wound healing after orthopedic surgery.” Scientific Reports. https://www.nature.com/articles/s41598-025-16747-2
- “Nattokinase.” Memorial Sloan Kettering Cancer Center. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/nattokinase
- “Nattokinase Drug Interactions and Contraindications.” Blueripple. https://blueripple.com/natto/natto-drug-interactions/
- “Lumbrokinase – A Potent and Stable Fibrin-Specific Plasminogen Activator.” International Journal of Bio-Science and Bio-Technology. https://gvpress.com/journals/IJBSBT/vol3_no2/5.pdf
- “Lumbrokinase regulates endoplasmic reticulum stress to improve neurological deficits in ischemic stroke.” ScienceDirect. https://www.sciencedirect.com/science/article/pii/S0028390822003367
- “Short-term inhibition of fibrinolytic system restores locomotor function after spinal cord injury in mice.” Scientific Reports. https://www.nature.com/articles/s41598-019-52621-8
- “Bromelain in Burn Care: Advancements in Enzymatic Debridement and Patient Outcomes.” PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11727150/